Why a diagnosis-specific hospital estimate matters
For international self-pay patients, the useful financial starting point is a specialist-reviewed treatment plan rather than a generic cancer price. The estimate should reflect the planned diagnostics, treatment modality, expected hospital or day-clinic care and known high-cost medicines or procedures; the final invoice can still change if the actual treatment episode differs.
Pathology confirmation can change the treatment plan
A hematology center may repeat or extend pathology, immunophenotyping or molecular testing because therapy depends on the exact lymphoma subtype. Ask whether external pathology review is included in the estimate.
Repeated systemic treatment needs a defined financial scope
Chemotherapy, antibody, targeted or other systemic treatment is usually delivered in cycles. A quotation should state how many cycles or which treatment phase it covers and whether medicines are included.
- Pathology / molecular review
- PET/CT or other staging
- Systemic medicines and number of cycles
- Day-clinic versus inpatient administration
- Supportive medicines and transfusions
- Stem-cell transplantation if planned
- CAR-T assessment or treatment when relevant
Advanced therapy should not be assumed from the diagnosis alone
Transplant and CAR-T are highly selected pathways with different eligibility, preparation and hospital-resource requirements. A generic lymphoma estimate should not be interpreted as including those treatments unless they are explicitly stated.
Official sources
Last source-reviewed 2026-08-30. Cost procedures and published service fees can change, so confirm current terms directly with the provider before transferring money or booking travel.
- International patient process and cost estimate — University Medical Center Hamburg-Eppendorf (UKE) ↗
- Cost Plan — LMU Klinikum International Patient Office ↗
- Finance for international patients — Heidelberg University Hospital ↗
- Lymphoma – patient information and appointments — National Center for Tumor Diseases Heidelberg ↗